{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:06:14Z","timestamp":1762113974742,"version":"build-2065373602"},"reference-count":117,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Government of the Novosibirsk oblast","award":["ML-1"],"award-info":[{"award-number":["ML-1"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Hematopoietic stem cell transplantation (HSCT) is a standard method for treating a number of pathologies, primarily blood diseases. Timely restoration of the immune system after HSCT is a critical factor associated with the development of complications such as relapses or secondary tumors and various infections, as well as the graft-versus-host reaction in allogeneic transplantation, which ultimately affects the survival of patients. Introduction into the recipient\u2019s body of immune system cells that are incapable of sensitization by recipient antigens during the period of immune reconstitution can increase the rate of restoration of the immune system, as well as reduce the risk of complications. This review presents the results of studies on cell therapy with various cell subpopulations of both bone marrow and mesenchymal origin during HSCT.<\/jats:p>","DOI":"10.3390\/cells13242056","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T09:38:15Z","timestamp":1733996295000},"page":"2056","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cell Therapy as a Way to Increase the Effectiveness of Hematopoietic Stem Cell Transplantation"],"prefix":"10.3390","volume":"13","author":[{"given":"Ekaterina","family":"Pashkina","sequence":"first","affiliation":[{"name":"Research Institute of Fundamental and Clinical Immunology, 14, Yadrintsevskaya st., 630099 Novosibirsk, Russia"},{"name":"Department of Clinical Immunology, Novosibirsk State Medical University, 52, Krasny Prospect, 630091 Novosibirsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3327-3630","authenticated-orcid":false,"given":"Elena","family":"Blinova","sequence":"additional","affiliation":[{"name":"Research Institute of Fundamental and Clinical Immunology, 14, Yadrintsevskaya st., 630099 Novosibirsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0298-2382","authenticated-orcid":false,"given":"Maria","family":"Bykova","sequence":"additional","affiliation":[{"name":"Research Institute of Fundamental and Clinical Immunology, 14, Yadrintsevskaya st., 630099 Novosibirsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Aktanova","sequence":"additional","affiliation":[{"name":"Research Institute of Fundamental and Clinical Immunology, 14, Yadrintsevskaya st., 630099 Novosibirsk, Russia"},{"name":"Department of Clinical Immunology, Novosibirsk State Medical University, 52, Krasny Prospect, 630091 Novosibirsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Denisova","sequence":"additional","affiliation":[{"name":"Research Institute of Fundamental and Clinical Immunology, 14, Yadrintsevskaya st., 630099 Novosibirsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.3324\/haematol.2019.245688","article-title":"History of hematopoietic cell transplantation: Challenges and progress","volume":"105","author":"Granot","year":"2020","journal-title":"Haematologica"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1182\/bloodadvances.2020001956","article-title":"Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents","volume":"4","author":"Roeker","year":"2020","journal-title":"Blood Adv."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Pockley, A.G., Lindsay, J.O., Foulds, G.A., Rutella, S., Gribben, J.G., Alexander, T., and Snowden, J.A. (2018). Immune Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Crohn\u2019s Disease: Current Status and Future Directions. A Review on Behalf of the EBMT Autoimmune Diseases Working Party and the Autologous Stem Cell Transplantation in Refractory CD-Low Intensity Therapy Evaluation Study Investigators. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00646"},{"key":"ref_4","first-page":"225","article-title":"The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer","volume":"395","author":"Cichocki","year":"2016","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.bbmt.2015.01.025","article-title":"Effect of Total Nucleated and CD34+ Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation","volume":"21","author":"Remberger","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jca.21946","article-title":"Total nucleated cell dose in graft is a better prognostic factor for survival in pediatric patients transplanted with bone marrow compared to CD34+, CD3+, or total mononuclear cell count","volume":"37","author":"Kupeli","year":"2022","journal-title":"J. Clin. Apher."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Orrantia, A., Terr\u00e9n, I., Astarloa-Pando, G., Gonz\u00e1lez, C., Uranga, A., Mateos-Maz\u00f3n, J.J., Garc\u00eda-Ruiz, J.C., Ri\u00f1\u00f3n, M., Rey, M., and P\u00e9rez-Fernandez, S. (2021). NK Cell Reconstitution After Autologous Hematopoietic Stem Cell Transplantation: Association Between NK Cell Maturation Stage and Outcome in Multiple Myeloma. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.748207"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"102045","DOI":"10.1016\/j.trim.2024.102045","article-title":"Early recovery of natural killer cells post T-cell depleted allogeneic stem cell transplantation using alemtuzumab \u201cin the bag\u201d","volume":"84","author":"Davison","year":"2024","journal-title":"Transpl. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.35754\/0234-5730-2020-65-1-24-38","article-title":"Reconstitution of T-cell-mediated immunity in patients after allogeneic stem cell transplantation","volume":"65","author":"Popova","year":"2020","journal-title":"Russ. J. Hematol. Transfusiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41577-020-00457-z","article-title":"T cell regeneration after immunological injury","volume":"21","author":"Velardi","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bbmt.2019.10.026","article-title":"Quantitative Analysis of Thymus-Independent Donor-Derived T Cell Expansion in Transplant Patients","volume":"26","author":"Gao","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Gaballa, A., Clave, E., Uhlin, M., Toubert, A., and Arruda, L.C.M. (2020). Evaluating Thymic Function After Human Hematopoietic Stem Cell Transplantation in the Personalized Medicine Era. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01341"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"van der Maas, N.G., Berghuis, D., van der Burg, M., and Lankester, A.C. (2019). B Cell Reconstitution and Influencing Factors After Hematopoietic Stem Cell Transplantation in Children. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00782"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ogonek, J., Kralj Juric, M., Ghimire, S., Varanasi, P.R., Holler, E., Greinix, H., and Weissinger, E. (2016). Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation. Front. Immunol., 7.","DOI":"10.3389\/fimmu.2016.00507"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.5045\/br.2023.2023004","article-title":"Transfusion support in hematopoietic stem cell transplantation","volume":"58","author":"Jekarl","year":"2023","journal-title":"Blood Res."},{"key":"ref_16","first-page":"65","article-title":"Platelets: Essential components of the immune system","volume":"16","author":"Ali","year":"2015","journal-title":"Curr. Trends Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.4049\/jimmunol.1800565","article-title":"The Evolving Erythrocyte: Red Blood Cells as Modulators of Innate Immunity","volume":"201","author":"Anderson","year":"2018","journal-title":"J. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Gaiffe, E., Vernerey, D., Bardiaux, L., Leroux, F., Meurisse, A., Bamoulid, J., Courivaud, C., Saas, P., Tiberghien, P., and Ducloux, D. (2022). Early Post-Transplant Red Blood Cell Transfusion Is Associated with an Increased Risk of Transplant Failure: A Nationwide French Study. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.854850"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/107327481502200108","article-title":"Transfusion support issues in hematopoietic stem cell transplantation","volume":"22","author":"Cohn","year":"2015","journal-title":"Cancer Control"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1111\/j.1600-6143.2007.01958.x","article-title":"Platelets an inflammatory force in transplantation","volume":"7","author":"Morrell","year":"2007","journal-title":"Am. J. Transplant."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bmt.1705246","article-title":"A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation","volume":"37","author":"Wandt","year":"2006","journal-title":"Bone Marrow Transplant."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.bbmt.2018.01.003","article-title":"Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation","volume":"24","author":"Hosoba","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/trf.12817","article-title":"Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation","volume":"55","author":"Christou","year":"2015","journal-title":"Transfusion"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"866.e1","DOI":"10.1016\/j.jtct.2021.07.001","article-title":"Platelet and Red Blood Cell Transfusions and Risk of Acute Graft-versus-Host Disease after Myeloablative Allogeneic Hematopoietic Cell Transplantation","volume":"27","author":"Hansen","year":"2021","journal-title":"Transplant. Cell Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/trf.17714","article-title":"Lack of RBC transfusion independence by Day 30 following allogeneic hematopoietic stem cell transplant strongly predicts inferior survival and high non-relapse mortality in acute myeloid leukemia patients","volume":"64","author":"Yuan","year":"2024","journal-title":"Transfusion"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"104039","DOI":"10.1016\/j.cellimm.2020.104039","article-title":"Application of molecular imaging technology in tumor immunotherapy","volume":"348","author":"Meng","year":"2020","journal-title":"Cell Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e12836","DOI":"10.14814\/phy2.12836","article-title":"Circulating granulocyte lifespan in compensated alcohol-related cirrhosis: A pilot study","volume":"4","author":"Potts","year":"2016","journal-title":"Physiol. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1182\/blood-2018-10-844571","article-title":"Neutrophils as regulators of the hematopoietic niche","volume":"133","author":"Lucas","year":"2019","journal-title":"Blood"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41423-020-00581-9","article-title":"Uncovering the multifaceted roles played by neutrophils in allogeneic hematopoietic stem cell transplantation","volume":"18","author":"Tecchio","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1182\/blood-2015-05-645986","article-title":"Efficacy of transfusion with granulocytes from G-CSF\/dexamethasone-treated donors in neutropenic patients with infection","volume":"126","author":"Price","year":"2015","journal-title":"Blood"},{"key":"ref_31","first-page":"e55953","article-title":"Granulocyte Transfusions in Neutropenic Infections: Insights from a Single-Center Study","volume":"16","author":"Kimiaei","year":"2024","journal-title":"Cureus"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"128","DOI":"10.46989\/001c.94135","article-title":"Transfusion Support in Hematopoietic Stem Cell Transplantation: A Contemporary Narrative Review","volume":"6","author":"Adkins","year":"2024","journal-title":"Clin. Hematol. Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1126\/science.1352912","article-title":"Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones","volume":"257","author":"Riddell","year":"1992","journal-title":"Science"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.bbmt.2016.08.006","article-title":"Selective Depletion of \u03b1\u03b2 T Cells and B Cells for Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation. A Three-Year Follow-Up of Procedure Efficiency","volume":"22","author":"Malaspina","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1080\/10428194.2018.1485905","article-title":"TCR \u03b1\u03b2+\/CD19+ cell depletion in haploidentical hematopoietic allogeneic stem cell transplantation: A review of current data","volume":"60","author":"Sahasrabudhe","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1182\/blood.2023021336","article-title":"TCR\u03b1\u03b2\/CD19 cell-depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: Updated final analysis","volume":"143","author":"Merli","year":"2024","journal-title":"Blood"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Abel, A.M., Yang, C., Thakar, M.S., and Malarkannan, S. (2018). Natural Killer Cells: Development, Maturation, and Clinical Utilization. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01869"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"551","DOI":"10.35754\/0234-5730-2022-67-4-551-569","article-title":"Impact of natural killer cell\u2019s functional reconstruction on the results of allogeneic hematopoietic stem cell transplantation","volume":"67","author":"Konova","year":"2022","journal-title":"Gematol. I Transfuziol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbmt.2009.12.008","article-title":"Expansion of NKG2A-LIR1-natural killer cells in HLA-matched, killer cell immunoglobulin-like receptors\/HLA-ligand mismatched patients following hematopoietic cell transplantation","volume":"16","author":"Rathmann","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1182\/blood-2010-08-264085","article-title":"Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation","volume":"117","author":"Moretta","year":"2011","journal-title":"Blood"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1172\/JCI1268","article-title":"Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation","volume":"101","author":"Asai","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1182\/blood-2009-05-222190","article-title":"NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects","volume":"115","author":"Olson","year":"2010","journal-title":"Blood"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/eji.201445200","article-title":"IL-12\/15\/18-preactivated NK cells suppress GvHD in a mouse model of mismatched hematopoietic cell transplantation","volume":"45","author":"Doisne","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jcyt.2016.12.006","article-title":"CD56-enriched donor cell infusion after post-transplantation cyclophosphamide for haploidentical transplantation of advanced myeloid malignancies is associated with prompt reconstitution of mature natural killer cells and regulatory T cells with reduced incidence of acute graft versus host disease: A pilot study","volume":"19","author":"Jaiswal","year":"2017","journal-title":"Cytotherapy"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1182\/blood-2014-07-592881","article-title":"Acute GVHD in patients receiving IL-15\/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation","volume":"125","author":"Shah","year":"2015","journal-title":"Blood"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Devillier, R., Calmels, B., Guia, S., Taha, M., Fauriat, C., Mfarrej, B., Venton, G., Vivier, E., Olive, D., and Chabannon, C. (2021). Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor. Cancers, 13.","DOI":"10.3390\/cancers13112673"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"100508","DOI":"10.1016\/j.xcrm.2022.100508","article-title":"Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma","volume":"3","author":"Nahi","year":"2022","journal-title":"Cell Rep. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1084\/jem.162.6.1745","article-title":"Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism","volume":"162","author":"Ljunggren","year":"1985","journal-title":"J. Exp. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1007\/s00277-023-05471-4","article-title":"A pilot study of cord blood-derived natural killer cells as maintenance therapy after autologous hematopoietic stem cell transplantation","volume":"102","author":"Wu","year":"2023","journal-title":"Ann. Hematol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41577-021-00595-y","article-title":"The discovery of innate lymphoid cells","volume":"21","author":"Vivier","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Xiong, L., Nutt, S.L., and Seillet, C. (2022). Innate lymphoid cells: More than just immune cells. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1033904"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2013-11-536888","article-title":"Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease","volume":"124","author":"Munneke","year":"2014","journal-title":"Blood"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/JLB.5A1019-522RR","article-title":"Innate lymphoid cell recovery and occurrence of GvHD after hematopoietic stem cell transplantation","volume":"111","author":"Piperoglou","year":"2022","journal-title":"J. Leukoc. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/ni.3553","article-title":"Evidence of innate lymphoid cell redundancy in humans","volume":"17","author":"Barlogis","year":"2016","journal-title":"Nat. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"101279","DOI":"10.1016\/j.smim.2019.06.002","article-title":"ILCs in hematologic malignancies: Tumor cell killers and tissue healers","volume":"41","author":"Blom","year":"2019","journal-title":"Semin. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jcyt.2021.10.011","article-title":"Presence of innate lymphoid cells in allogeneic hematopoietic grafts correlates with reduced graft-versus-host disease","volume":"24","author":"Kroeze","year":"2022","journal-title":"Cytotherapy"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1172\/JCI91816","article-title":"Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease","volume":"127","author":"Bruce","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1182\/bloodadvances.2020001514","article-title":"Third-party type 2 innate lymphoid cells prevent and treat GI tract GvHD","volume":"5","author":"Bruce","year":"2021","journal-title":"Blood Adv."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6000","DOI":"10.1038\/s41467-024-50263-7","article-title":"Type II innate lymphoid cell plasticity contributes to impaired reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"15","author":"Laurie","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Latha, T.S., Reddy, M.C., Durbaka, P.V., Rachamallu, A., Pallu, R., and Lomada, D. (2014). \u03b3\u03b4 T Cell-Mediated Immune Responses in Disease and Therapy. Front. Immunol., 5.","DOI":"10.3389\/fimmu.2014.00571"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4049\/jimmunol.1601100","article-title":"Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation: Time to T up the Thymus","volume":"198","author":"Chaudhry","year":"2017","journal-title":"J. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Dekker, L., de Koning, C., Lindemans, C., and Nierkens, S. (2020). Reconstitution of T Cell Subsets Following Allogeneic Hematopoietic Cell Transplantation. Cancers, 12.","DOI":"10.3390\/cancers12071974"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbmt.2018.02.023","article-title":"Early Reconstitution of NK and \u03b3\u03b4 T Cells and Its Implication for the Design of Post-Transplant Immunotherapy","volume":"24","author":"Sarhan","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Gaballa, A., Arruda, L.C.M., and Uhlin, M. (2022). Gamma delta T-cell reconstitution after allogeneic HCT: A platform for cell therapy. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.971709"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1182\/blood-2014-09-599423","article-title":"\u03b3\u03b4 T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-\u03b1\u03b2+\/CD19+ lymphocytes","volume":"125","author":"Airoldi","year":"2015","journal-title":"Blood"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"334","DOI":"10.37349\/ei.2022.00054","article-title":"Allogeneic gamma delta T cells as adoptive cellular therapy for hematologic malignancies","volume":"2","author":"Jhita","year":"2022","journal-title":"Explor. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1158\/1078-0432.CCR-06-2602","article-title":"The graft content of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors","volume":"13","author":"Pabst","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-065X.2001.1820102.x","article-title":"Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: Their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance","volume":"182","author":"Sakaguchi","year":"2001","journal-title":"Immunol. Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1084\/jem.193.11.1311","article-title":"CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade","volume":"193","author":"Taylor","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.4049\/jimmunol.166.6.3789","article-title":"IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo","volume":"166","author":"Hara","year":"2001","journal-title":"J. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/bmt.2012.232","article-title":"Frequency of CD4(+)FOXP3(+) regulatory T-cells at early stages after HLA-mismatched allogeneic hematopoietic SCT predicts the incidence of acute GVHD","volume":"48","author":"Fujioka","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.leukres.2017.01.014","article-title":"Level of Granzyme B-positive T-regulatory cells is a strong predictor biomarker of acute Graft-versus-host disease after day + 30 after allo-HSCT","volume":"54","author":"Drokov","year":"2017","journal-title":"Leuk. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"27305","DOI":"10.18632\/oncotarget.25553","article-title":"Increased circulating CD4+FOXP3+ T cells associate with early relapse following autologous hematopoietic stem cell transplantation in multiple myeloma patients","volume":"9","author":"Batorov","year":"2018","journal-title":"Oncotarget"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1182\/blood-2006-02-003996","article-title":"High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT","volume":"108","author":"Rezvani","year":"2006","journal-title":"Blood"},{"key":"ref_76","first-page":"537","article-title":"Effect of donor CD4+CD25+ regulatory T cells on hematopoietic and immune reconstitution, GVHD and disease-free survival after allogeneic hematopoietic stem cell transplantation","volume":"28","author":"Yang","year":"2008","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao = J. S. Med. Univ."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Guo, W.W., Su, X.H., Wang, M.Y., Han, M.Z., Feng, X.M., and Jiang, E.L. (2021). Regulatory T Cells in GVHD Therapy. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.697854"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1182\/blood-2006-08-044529","article-title":"In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation","volume":"109","author":"Nguyen","year":"2007","journal-title":"Blood"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41375-019-0625-3","article-title":"Efficient treatment of murine acute GvHD by in vitro expanded donor regulatory T cells","volume":"34","author":"Riegel","year":"2020","journal-title":"Leukemia"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.4049\/jimmunol.1301181","article-title":"Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivo","volume":"191","author":"Zhang","year":"2013","journal-title":"J. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e1146842","DOI":"10.1080\/2162402X.2016.1146842","article-title":"CD8(+) Tregs promote GVHD prevention and overcome the impaired GVL effect mediated by CD4(+) Tregs in mice","volume":"5","author":"Heinrichs","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation","volume":"117","author":"Falzetti","year":"2011","journal-title":"Blood"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.beha.2011.05.005","article-title":"Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation","volume":"24","author":"Falzetti","year":"2011","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: Safety profile and detection kinetics","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1182\/blood-2015-06-653667","article-title":"Umbilical cord blood-derived T regulatory cells to prevent GVHD: Kinetics, toxicity profile, and clinical effect","volume":"127","author":"Brunstein","year":"2016","journal-title":"Blood"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2009.06.001","article-title":"First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127\u2212 T regulatory cells","volume":"133","author":"Trzonkowski","year":"2009","journal-title":"Clin. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jcyt.2014.11.005","article-title":"Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease","volume":"17","author":"Theil","year":"2015","journal-title":"Cytotherapy"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1182\/bloodadvances.2020003739","article-title":"Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia","volume":"5","author":"Pierini","year":"2021","journal-title":"Blood Adv."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Sayitoglu, E.C., Freeborn, R.A., and Roncarolo, M.G. (2021). The Yin and Yang of Type 1 Regulatory T Cells: From Discovery to Clinical Application. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.693105"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Bacchetta, R., Lucarelli, B., Sartirana, C., Gregori, S., Lupo Stanghellini, M.T., Miqueu, P., Tomiuk, S., Hernandez-Fuentes, M., Gianolini, M.E., and Greco, R. (2014). Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells. Front. Immunol., 5.","DOI":"10.3389\/fimmu.2014.00016"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Mar\u00edn Morales, J.M., M\u00fcnch, N., Peter, K., Freund, D., Oelschl\u00e4gel, U., H\u00f6lig, K., B\u00f6hm, T., Flach, A.C., Ke\u00dfler, J., and Bonifacio, E. (2019). Automated Clinical Grade Expansion of Regulatory T Cells in a Fully Closed System. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00038"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nri.2015.18","article-title":"Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease","volume":"16","author":"DuPage","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Andersen, K.G., Butcher, T., and Betz, A.G. (2008). Specific immunosuppression with inducible Foxp3-transduced polyclonal T cells. PLoS Biol., 6.","DOI":"10.1371\/journal.pbio.0060276"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1172\/JCI82771","article-title":"Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor","volume":"126","author":"MacDonald","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.ymthe.2017.06.029","article-title":"IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism","volume":"25","author":"Locafaro","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/ajt.14175","article-title":"Prevention of Allograft Rejection by Use of Regulatory T Cells with an MHC-Specific Chimeric Antigen Receptor","volume":"17","author":"Noyan","year":"2017","journal-title":"Am. J. Transplant."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.3324\/haematol.2020.263129","article-title":"Engineered type 1 regulatory T cells designed for clinical use kill primary pediatric acute myeloid leukemia cells","volume":"106","author":"Cieniewicz","year":"2021","journal-title":"Haematologica"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev-cellbio-100913-013132","article-title":"\u201cMesenchymal\u201d stem cells","volume":"30","author":"Bianco","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00109-023-02371-y","article-title":"Potential role of mesenchymal stem cells in T cell aging","volume":"101","author":"Zhong","year":"2023","journal-title":"J. Mol. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1084\/jem.20110132","article-title":"The bone marrow stem cell niche grows up: Mesenchymal stem cells and macrophages move in","volume":"208","author":"Ehninger","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1097\/HS9.0000000000000151","article-title":"Mesenchymal stromal cells: Role in the BM niche and in the support of hematopoietic stem cell transplantation","volume":"2","author":"Crippa","year":"2018","journal-title":"Hemasphere"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/14653240310003611","article-title":"Immunomodulatory effects of fetal and adult mesenchymal stem cells","volume":"5","year":"2003","journal-title":"Cytotherapy"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/sj.leu.2404777","article-title":"Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells","volume":"21","author":"Samuelsson","year":"2007","journal-title":"Leukemia"},{"key":"ref_104","first-page":"2764","article-title":"Cotransplantation of ex vivo\u2013expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation","volume":"110","author":"Ball","year":"2007","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cellimm.2015.07.001","article-title":"Mesenchymal stromal cells improve early lymphocyte recovery and T cell reconstitution after autologous hematopoietic stem cell transplantation in patients with malignant lymphomas","volume":"297","author":"Batorov","year":"2015","journal-title":"Cell. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"139","DOI":"10.15789\/1563-0625-2014-2-139-148","article-title":"Possible mechanisms of stimulatory effects of mesenchymal stromal cells upon t cell recovery during chemotherapy-induced lymphopenia","volume":"16","author":"Batorov","year":"2014","journal-title":"Med. Immunol."},{"key":"ref_107","first-page":"202","article-title":"Effect of mesenchymal stromal cells on the early reconstitution of T-lymphocytes in malignant lymphoma patients with autologous hematopoietic stem cell transplantation","volume":"34","author":"Chernykh","year":"2013","journal-title":"Immunology"},{"key":"ref_108","first-page":"8","article-title":"Autologous mesenchymal stromal cells of hemoblastosis patients efficiently support hematopoietic recovery after stem cell transplantation","volume":"1","author":"Sergeevicheva","year":"2010","journal-title":"Cell. Ther. Transplant."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1207285","article-title":"Cord-blood engraftment with ex vivo mesenchymal-cell coculture","volume":"367","author":"McNiece","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.bbmt.2017.05.002","article-title":"Ex vivo mesenchymal precursor cell\u2013expanded cord blood transplantation after reduced-intensity conditioning regimens improves time to neutrophil recovery","volume":"23","author":"Mehta","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.leu.2405090","article-title":"The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: Outcome of a pilot clinical study","volume":"22","author":"Ning","year":"2008","journal-title":"Leukemia"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13287-015-0155-5","article-title":"Mesenchymal stromal cells enhance the engraftment of hematopoietic stem cells in an autologous mouse transplantation model","volume":"6","author":"Herrera","year":"2015","journal-title":"Stem Cell Res. Ther."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/16078454.2022.2042064","article-title":"Primary graft failure following allogeneic hematopoietic stem cell transplantation: Risk factors, treatment and outcomes","volume":"27","author":"Chen","year":"2022","journal-title":"Hematology"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Stenger, E.O., Krishnamurti, L., and Galipeau, J. (2015). Mesenchymal stromal cells to modulate immune reconstitution early post-hematopoietic cell transplantation. BMC Immunol., 16.","DOI":"10.1186\/s12865-015-0135-7"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e536","DOI":"10.1002\/hsr2.536","article-title":"Post-hematopoietic stem cell transplantation relapse: Role of checkpoint inhibitors","volume":"5","author":"Roshandel","year":"2022","journal-title":"Health Sci. Rep."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.15789\/1563-0625-IOG-2167","article-title":"Impact of graft-versus-host disease prophylaxis on immune reconstitution in patients after allogeneic hematopoietic stem cell transplantation","volume":"23","author":"Mikhaltsova","year":"2021","journal-title":"Med. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Yanir, A., Schulz, A., Lawitschka, A., Nierkens, S., and Eyrich, M. (2022). Immune Reconstitution After Allogeneic Haematopoietic Cell Transplantation: From Observational Studies to Targeted Interventions. Front. Pediatr., 9.","DOI":"10.3389\/fped.2021.786017"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/24\/2056\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:53:44Z","timestamp":1760115224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/24\/2056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":117,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["cells13242056"],"URL":"https:\/\/doi.org\/10.3390\/cells13242056","relation":{},"ISSN":["2073-4409"],"issn-type":[{"type":"electronic","value":"2073-4409"}],"subject":[],"published":{"date-parts":[[2024,12,12]]}}}